Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Xida Yonghe Technology Development is a biotechnology company based in Xi'an, China, specializing in the development of recombinant collagen-based biomaterials. Founded in 2001 in collaboration with Northwest University, the company is a pioneer in the production of "Human-like Collagen" (HLC) using genetic engineering techniques. Its core business involves the manufacturing of medical devices, including wound dressings, skin repair gels, and aesthetic treatments for dermatology. The company's technology platform allows for the production of collagen that is highly biocompatible and low in immunogenicity compared to animal-derived alternatives. As a key subsidiary of Giant Biogene, Xida Yonghe plays a critical role in the industrialization of high-tech medical and skincare products in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Xida Yonghe Technology Development.